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Carum carvi is a widely available herb that has been used as a food additive and as a medication in traditional
medicine for many years. Its potential biological effects include analgesic, anti-inflammatory, anti-anxiety and
antispasmodic activities. We report a patient with papillary thyroid carcinoma who were under treatment with
levothyroxine and experienced an elevated TSH level by ingestion of Carum carvi. TSH level was increased to
60.3 mIU/L with no change in levothyroxine dosage and decreased to normal range after discontinuation of the
Carum carvi. Observing this dramatic change in TSH level by carum ingestion, carum carvi capsules was produced
and one of the researcher tried the medication on herself with a dose of 40 mg/kg/day. She had a history of
hypothyroidism and was taking 100 ugr/day of levothyroxine. TSH was markedly increased 2 weeks after ingestion
of Carum carvi and returned to normal range 5 months after discontinuation of it. This case report shows the effect
of consumption of Carum carvi in increasing TSH level in hypothyroid patients treating with levothyroxine. The
exact mechanism of action of carum carvi remains unknown.
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Medicinal plants play a key role in several physiologic
and pathologic processes in our body and there are
many effects which are still to be discovered. Carum
carvi (black zeera) from Apiaceae family has various bio-
logical effects including analgesic, anti-inflammatory,
anti-anxiety and antispasmodic activities which provide
pharmacological basis for its use in hyperactivity disor-
ders of gut and airways, such as diarrhea, colic and
asthma [1-9]. It seems to be a safe food additive com-
monly used in our daily life but its effect on thyroid hor-
mones remains unknown.
In this study we are reporting two patients with
hypothyroidism, under treatment with levothyroxine, who
showed elevated TSH levels after ingestion of Carum
carvi. This is the first report on effect of carum on thyroid
hormones level in patients treating with levothyroxine.* Correspondence: zakavir@mums.ac.ir
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The first case was a 24-years-old girl (weight: 44.2 kg)
with advanced papillary thyroid cancer (T4N1bM1) who
had a history of near total thyroidectomy, external radio-
therapy of the neck and mediastinum and repeated
radio-iodine therapy in the last 17 years. She had bilat-
eral lung metastases and received 34.4 GBq of I-131 dur-
ing her treatment. She was under suppressive therapy
with 100 μg/day of levothyroxine. She was also taking
calcium carbonate 1000 mg/day and calcitriol 0.25 μg/
day. Her TSH level ranged from 0.07-0.3 mIU/L during
follow up consistent with subclinical hyperthyroidism.
During her last follow up, TSH and T3RIA level were
found to be 60.3 μU/L and 135.9 ng/ml, respectively.
Padyab Teb kits was used for measurement of TSH
(interassay CV = 8.21%, Intra-assay CV = 5.41%, Padyab
Teb, IRI) and T3RIA (interassay CV = 5.56%, intra-assay
CV = 5.45%). The laboratory results were repeated and
TSH and T3RIA level were 60.72 mIU/L and 150.2 ng/
ml, respectively. She had no complaint except occasional
cough and dyspnea which were due to bilateral lung me-
tastasis. Biochemically, she was considered hypothyroid.
Complete interview was done to find the reason behind
the elevated TSH level during levothyroxine consumption.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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her drug regimen had not been changed during last
6 months. The only new food additive, she was receiving
was Carum carvi seed and yarrow. Dose of levothyroxine
was not changed and Carum carvi and yarrow consump-
tion was stopped. After 2 months of discontinuation of
Carum carvi and yarrow consumption, measurement of
thyroid hormones was performed using the same kits in
the same laboratory. The new TSH and T3RIA levels were
1.75 mIU/l and 166.07 ng/ml, respectively indicating eu-
thyroid state. This observation was assessed by Naranjo
causality index and found a “possible adverse drug reac-
tion” (score 3) while using WHO-UMC causality scale it
was considered a “probable” ADR. Written informed con-
sent was obtained from the patient for publication of this
Case report and any accompanying images.
Considering the dramatic change in TSH level by
carum ingestion, Carum carvi capsules containing 200,
400 and 800 mg of powdered Carum carvi was pro-
duced in School of Pharmacy and one of the researchers
with history of hypothyroidism tried to test it on her.
She was a 24-years-old girl (weight = 45 kg) with a his-
tory of hypothyroidism for 5 years and had been treating
with 100 μg/day of levothyroxine. TSH level was be-
tween 2.5-3.7 mIU/l in her medical records. In the first
visit, all clinical signs and symptoms were assessed and
none of hypothyroid symptoms were observed. Her
pulse rate was 76/min and her blood pressure was 90/
70 mmHg. In physical examination, she had a painless,
small goiter with no palpable nodule or adenopathy. She
was not taking any other medication and her mother
had a history of hypothyroidism as well. Her initial TSH
level before starting Carum carvi was 2.3 mIU/L, indi-
cating euthyroidism. She started to take carum with dose
of 1800 mg/day (40 mg/kg) divided in 3 doses. The dose
of 40 mg/kg was 1% of the maximum safe dose of
Carum carvi in rats. Levothyroxine was ingested in fast-
ing state in early morning and carum capsules were used
after each meal (breakfast, lunch and dinner). After
2 weeks, TSH level was 26 mIU/l and thyroid hormone
levels were decreased indicating hypothyroid state (Table 1).Table 1 Hormonal levels in different time points after
carum ingestion and discontinuation
Carum ingestion Carum discontinued
Time Beginning 2 weeks 6 weeks 8 weeks 12 weeks
TSH (mIU/L) 2.3 26 110 25 11
T4RIA (ng/L) 11 12 3.7 4.6 9
T3RIA (ng/L) 148 106 57 90 143
T3RU (%) 30 31 26 24 30
TSH = Thyroid stimulating hormone, T4RIA = T4 Radio-immuno-assay,
T3RIA = T3-Radio-immuno-assay, T3RU = T3 Resin uptake.Vital signs remained in normal range (PR: 80 and BP: 90/
70). In physical examination, no new change was observed
but she suffered from dry and cold skin. She continued
using carum capsules for 4 additional weeks when she
started to complain from constipation. At the same time,
TSH level increased to 110 mIU/L, and thyroid hormone
level was further decreased (Table 1). Thyroid exam was
unchanged while she was in hypothyroid state both bio-
chemically and clinically. Carum carvi was discontinued
and thyroid values was measured after 2 weeks and
showed TSH level of 25 mIU/L. Dose of Levothyroxine
was not changed and thyroid values were measured again
6 weeks after discontinuation of Carum carvi. The TSH
level further decreased to 11 mIU/l and T4RIA level was
increased to 9 ng/L (Table 1). Two months later, TSH
was further decreased to 7 mIU/l with no intervention
indicating subclinical hypothyroid state. The patient ob-
tained 7 scores in Naranjo causality algorithm (probable
ADR) and categorized as “certain ADR” in WHO-UMC
score.
Discussion
In the present study, we observed dramatic effect of
oral administration of Carum carvi seed on TSH level
in patients with hypothyroidism. Although one of our
patients had follicular thyroid cancer and the other
had hypothyroidism due to autoimmune thyroiditis,
both patients was receiving levothyroxine and showed
marked elevation of TSH level after ingestion of carum
seeds.
Carum carvi has been used traditionally as an ac-
ceptable food additive and its beneficial effect was re-
ported in treating diarrhea, colic and asthma. Due to
its antispasmodic activity, it was used in gastrointes-
tinal disorders and as bronchodilator in hyperactive
airways [1,6]. In addition, studies indicated that cara-
way oil probably has a protective antioxidant role in
heart and kidney in patients with sepsis [10]. The
mechanism of the effect of Carum carvi in our patients
is unknown. Our first patient was receiving carum and
yarrow while the second patient was receiving carum
only. As the effect was similar in both patients, it
seems that carum effect is more prominent than any
possible effect of yarrow.
Some herbal products were reported to change thyroid
metabolism. Soy consumption is related to thyroid disor-
ders such as hypothyroidism, goiter, and autoimmune
thyroid disease besides increased iodine metabolism in
animal studies but the exact molecular mechanisms
which might be responsible for hypothyroidism is un-
clear [11]. In our patients, hypothyroidism could not be
related to iodine metabolism as both patients were tak-
ing levothyroxine. It was found that the peel extracts of
Mangifera indica, Citrullus vulgaris, and Cucumis melo
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and T4 which is indicative of the role of these peel
extracts in ameliorating hypothyroidism [12,13]. The
possible reasons for this beneficial role may be attributed
to the presence of flavonoids, phenolic compounds, and
ascorbic acid content of the peel extracts [12,14]. Full
phytochemical analysis of both essential oil and seed
extract showed the presence of many mono and sesqui-
terpenes in essential oil and diverse flavonoids, isoflavo-
noids, flavonoid glycosides, monoterpenoid glucosides,
lignins and alkaloids and other phenolic compounds in
seed extract [13,15-17]. However, none of these com-
pounds has been specifically linked to a mechanism by
which TSH elevation could be explained.
In our patient, the mechanism of TSH elevation may
be attributed to prevention of absorption of levothyrox-
ine in the bowel and/or its action in the receptor level.
Since in our trial case, T4 and T3 levels decreased by
consumption of Carum carvi, the most plausible explan-
ation would be the interference with levothyroxine ab-
sorption. This hypothesis is also supported by the
observation that hypothyroidism was gradually becom-
ing severe and symptoms of hypothyroidism were more
prominent at the end of the experiment. Interestingly,
symptoms and signs of hypothyroidism were not prom-
inent in our patient early after experiment, suggesting
that peripheral action of the hormone is well preserved.
Moreover, this finding may suggest that Carum may
have more prominent effects on blocking of T4 to T3
conversion at the hypophysis.
Many causality scoring systems have been used for
evaluation of adverse drug reaction. We used Naranjo
score and WHO-UMC in our patients and it was “prob-
able” and “certain” ADR according to these categories,
respectively [18].
The carum seeds consumption did not produce any
observable toxicity based on evaluated signs and symp-
toms at the dose of 40 mg/kg [3]. However, more exten-
sive toxicity assessments are required to make sure that
the seeds are safe at the dose of 40 mg/kg.
Conclusion
This case report shows that consumption of Carum
carvi interfere with levothyroxine effect in hypothyroid
patients and increase TSH prominently. The exact
mechanism of action of Carum carvi is not known.
Informing patients and physicians about the possible
interaction of Carum carvi on TSH elevation would be
helpful.
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